EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?-Reference-Cited by-同舟云学术

EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

Published:2017-03-28 Issue:7 Volume:60 Page:1218-1222
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Blond Emilie,Disse Emmanuel,Cuerq Charlotte,Drai Jocelyne,Valette Pierre-Jean,Laville Martine,Thivolet Charles,Simon Chantal,Caussy Cyrielle

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-017-4264-9/fulltext.html

Reference10 articles.

1. Bellentani S (2017) The epidemiology of non-alcoholic fatty liver disease. Liver Int 37(Suppl 1):81–84

2. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84

3. Dulai PS, Singh S, Patel J et al (2017) Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. doi: 10.1002/hep.29085

4. Ekstedt M, Hagstrom H, Nasr P et al (2015) Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61:1547–1554

5. Angulo P, Kleiner DE, Dam-Larsen S et al (2015) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149:389–397 e310

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population;Clinics and Research in Hepatology and Gastroenterology;2024-08

2. Ramadan Fasting in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Transplant, and Bariatric Surgery: A Narrative Review;Journal of Clinical Medicine;2024-07-02

3. Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease;International Journal of Molecular Sciences;2024-04-30

4. Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-04

5. Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress;Nutrition & Metabolism;2024-03-08